Offer - Urjas Oil for just ₹ 1 X
StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet is an allopathic medicine The correct dosage of StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet. It is best to stop taking StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet immediately and inform your doctor if you notice any discomfort.
Is the use of StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet safe during breastfeeding?
Side effects of StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet on the Kidneys?
StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet may have mild side effects on the kidneys.
What is the effect of StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet on the Liver?
StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet is rarely harmful for the liver.
What is the effect of StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet on the Heart?
StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet may have mild side effects on the heart. Most people will never see any effect on the heart.
StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet unless your doctor advises you to do so -
Is this StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet habit forming or addictive?
Forming a habit of StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet has not been reported.
Interaction between Food and StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet
Taking StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet with food does not harm your health.
Interaction between Alcohol and StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet
Information about the interaction of StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet and alcohol is not currently available because this topic has not been researched yet.
Yes, [medicine] can cause stomach upset. It is a common side effect of this drug. Please inform your doctor if you are experiencing stomach upset after taking this medicine.
Take StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet as directed by your doctor. Do not discontinue the drug suddenly or take it longer than prescribed by your doctor.
There is no fixed rule to take this Medicine], this drug can be taken during any time of the day as per doctor's instructions. However, taking it in the evening is more advisable because this drug can cause sleepiness and drowsiness. Activities such as driving and operating heavy machinery should be avoided after taking this StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet to prevent accidents and injuries.
No, taking StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet does not cause weight gain. However, long-term usage of this drug may rarely cause some weight gain. You are recommended to inform your doctor if you are experiencing any weight gain while consuming StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet.
StayHappi Cetirizine + Paracetamol + Phenylepherine Hydrochloride Tablet works by blocking the action of histamine which is responsible for allergies in our body. This helps to relieve symptoms of allergies, such as a runny nose, sneezing, and redness, watery, itchy eyes. This drug also helps to relieve itching caused due to urticaria (hives).
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 166-167
April Hazard Vallerand, Cynthia A. Sanoski. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 316-317
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; ZYRTEC® (cetirizine hydrochloride) Tablets and Syrup For Oral Use
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vazculep (phenylephrine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 135-136
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1020-1022